Hope, Hype, and Trust in Sickle Cell Disease

This Viewpoint discusses how to communicate trust for novel rare disease treatments using lessons learned from sickle cell disease.

Corresponding Author: Yoram Unguru, MD, MS, MA, Division of Pediatric Hematology/Oncology, The Herman and Walter Samuelson Children’s Hospital at Sinai, 2401 W Belvedere Ave, Baltimore, MD 21215-5271 (yunguru@lifebridgehealth.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.